This bill matters because it would create a significant carve-out in federal tobacco regulation, specifically for premium cigars. If passed, it means that one type of tobacco product would not be overseen by the Food and Drug Administration (FDA), an agency generally tasked with protecting public health by regulating food, drugs, and cosmetics, including tobacco.

For voters, this bill could impact the cost and availability of premium cigars, as manufacturers might face fewer regulatory hurdles. It also raises questions about public health policy, as it would exempt these products from the health-related oversight applied to other tobacco products. If the bill doesn't pass, premium cigars would continue to be regulated by the FDA, potentially meaning more rules, higher compliance costs for businesses, and potentially different product options for consumers.